Tag: pharmacovigilance and drug safety software market outlook

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Pharmacovigilance And Drug Safety Software Market Size Forecast: How Big Could The Market Get By 2030?#_x000D_

The pharmacovigilance and drug safety software market has experienced substantial expansion in recent times. This market is projected to expand from $2.53 billion in 2025 to $2.86 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to its historical growth include a rise in adverse drug reaction reporting, the global expansion of clinical trials, stricter drug safety regulations, an increase in pharmaceutical manufacturing, and escalating demands for post-marketing surveillance._x000D_

_x000D_

The pharmacovigilance and drug safety software market is projected for substantial expansion over the coming years. This market is set to reach $4.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. Factors contributing to this anticipated growth during the forecast period encompass the proliferation of AI-driven signal detection, the rise in biologics and specialty drugs, intensified regulatory oversight, increased outsourcing of pharmacovigilance services, and the need for real-time safety analytics. Significant trends expected during this period include the wider acceptance of cloud-based pharmacovigilance platforms, a heightened emphasis on real-world evidence monitoring, greater automation in adverse event reporting, the extension of integrated drug safety systems, and a stronger demand for solutions ensuring regulatory compliance._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=30537089&type=smp&name=Pharmacovigilance%20And%20Drug%20Safety%20Software%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmacovigilance And Drug Safety Software Market Growth Factors: What’s Supporting Expansion?#_x000D_

The increasing need for personalized medicine is anticipated to drive expansion in the pharmacovigilance and drug safety software market going forward. Personalized medicine, also referred to as precision medicine, is a healthcare approach that tailors treatment decisions to an individual’s genetic, biological, and lifestyle characteristics. The demand for personalized medicine is escalating due to improved treatment outcomes, more effective prevention and early detection strategies, and greater cost-effectiveness. The pharmacovigilance and drug safety software market supports personalized medicine by integrating pharmacogenetics, real-time data analytics, and post-marketing surveillance to optimize patient safety, monitor individualized treatments, and strengthen risk-management practices. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from 6 approvals in 2022. Therefore, the expanding demand for personalized medicine is fueling the growth of the pharmacovigilance and drug safety software market._x000D_

_x000D_

#Pharmacovigilance And Drug Safety Software Market Segmentation And Category Overview#_x000D_

The pharmacovigilance and drug safety software market covered in this report is segmented – _x000D_

_x000D_

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software_x000D_

2) By Delivery Mode: On-premise, Cloud-based_x000D_

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications_x000D_

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules_x000D_

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms_x000D_

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools_x000D_

_x000D_

#Pharmacovigilance And Drug Safety Software Market Industry Trends: What’s Reshaping Demand?#_x000D_

Major companies operating in the pharmacovigilance and drug safety software market are strategically developing innovative technologies, such as cloud-based data lake platforms, to strengthen adverse event monitoring, improve regulatory compliance, and enhance overall patient safety across clinical trials and post-market surveillance activities. A cloud-based data lake platform is defined as a scalable, centralized system capable of storing and analyzing large volumes of both structured and unstructured safety data in real time, thereby enabling advanced analytics, AI/ML modeling, and streamlined case processing within pharmacovigilance workflows. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched CorEvidence, a proprietary cloud-based data lake platform designed to optimize pharmacovigilance processes by improving safety data management and case processing efficiency, particularly supporting post-authorization safety studies within clinical research registries._x000D_

_x000D_

#Pharmacovigilance And Drug Safety Software Market Competitive Analysis Of Leading Industry Participants#_x000D_

Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel _x000D_

_x000D_

#View The Full Pharmacovigilance And Drug Safety Software Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmacovigilance And Drug Safety Software Market Top Region By Revenue And Market Share#_x000D_

North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Pharmacovigilance And Drug Safety Software Market Revenue Growth Supported By A CAGR Of 4.6% Through 2030

A rapid expansion has been observed in the pharmacovigilance and drug safety software market over recent years, with projections indicating a rise from $2.53 billion in 2025 to $2.86 billion in 2026, representing a compound annual growth rate (CAGR) of 12.8%. This historical growth has been driven by several factors, including increased reporting of adverse drug reactions, the global expansion of clinical trials, stricter drug safety regulations, heightened pharmaceutical production, and a growing need for post-marketing surveillance.

Over the coming years, the pharmacovigilance and drug safety software market is anticipated to expand at a significant pace, reaching a valuation of $4.6 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.6%. This projected growth during the forecast period is fueled by several key factors, including the expansion of AI-driven signal detection, the increased development of biologics and specialty drugs, heightened regulatory oversight, a growing trend toward outsourcing pharmacovigilance activities, and an escalating need for real-time safety analytics. Notable trends shaping this period involve a higher uptake of cloud-based pharmacovigilance systems, a stronger emphasis on real-world evidence monitoring, greater automation in the reporting of adverse events, the expansion of integrated drug safety platforms, and an increased demand for compliance-focused safety solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmacovigilance And Drug Safety Software Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing need for personalized medicine is expected to accelerate expansion in the pharmacovigilance and drug safety software market moving forward. Personalized medicine, often referred to as precision medicine, is a healthcare model that customizes treatment plans based on an individual’s genetic, biological, and lifestyle factors. This rise in demand is fueled by better therapeutic outcomes, enhanced capabilities for prevention and early diagnosis, and greater cost efficiency. The pharmacovigilance and drug safety software market facilitates personalized medicine through the incorporation of pharmacogenetics, real-time data analytics, and post-marketing surveillance to improve patient safety, oversee tailored therapies, and reinforce risk management protocols. As an example, in February 2024, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, reported that the FDA sanctioned 16 novel personalized therapies for individuals with rare diseases in 2023, up from just 6 approvals in 2022. Consequently, the rising demand for personalized medicine is fueling growth in the pharmacovigilance and drug safety software market.

Pharmacovigilance And Drug Safety Software Market Segment Analysis And Revenue Opportunities

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

Pharmacovigilance And Drug Safety Software Market Trends Reshaping Industry Growth

Key players within the pharmacovigilance and drug safety software market are increasingly concentrating on the creation of advanced technologies, including cloud-based data lake platforms, to bolster adverse event tracking, enhance adherence to regulatory standards, and elevate patient safety during clinical trials and after-market monitoring. Such a cloud-based data lake platform represents a scalable and centralized system capable of storing and analyzing substantial amounts of structured and unstructured safety information in real time, which facilitates sophisticated analytics, artificial intelligence and machine learning modeling, and efficient case management in pharmacovigilance operations. As an example, in December 2023, Thermo Fisher Scientific Inc., a biotechnology firm headquartered in the United States, introduced CorEvidence, a proprietary cloud-based data lake platform aimed at streamlining pharmacovigilance procedures by refining safety data administration and case processing effectiveness, especially for post-authorization safety studies within clinical research registries.

Pharmacovigilance And Drug Safety Software Market Leading Players Shaping Industry Direction

Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel

Access The Complete Pharmacovigilance And Drug Safety Software Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmacovigilance And Drug Safety Software Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Pharmacovigilance And Drug Safety Software Market Through 2030?

The pharmacovigilance and drug safety software market has seen rapid expansion in recent years. It is anticipated to increase from $2.53 billion in 2025 to $2.86 billion in 2026, at a compound annual growth rate (CAGR) of 12.8%. This historical growth can be attributed to factors such as a rise in adverse drug reaction reporting, the globalization of clinical trials, stringent drug safety regulations, an increase in pharmaceutical production, and evolving requirements for post-marketing surveillance.

The market for pharmacovigilance and drug safety software is projected for swift expansion over the coming years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. This projected growth during the forecast period stems from factors such as the expansion of AI-driven signal detection, the growth in biologics and specialty drugs, heightened regulatory scrutiny, the increasing outsourcing of pharmacovigilance services, and the demand for real-time safety analytics. Key trends anticipated for the forecast period encompass the growing adoption of cloud-based pharmacovigilance platforms, an increasing focus on real-world evidence monitoring, a rising automation in adverse event reporting, the expansion of integrated drug safety systems, and a higher demand for regulatory compliance solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Are The Main Drivers Accelerating The Growth Of The Pharmacovigilance And Drug Safety Software Market?

The increasing need for personalized medicine is anticipated to drive expansion in the pharmacovigilance and drug safety software market. This approach, also known as precision medicine, involves customizing treatment strategies based on an individual’s unique genetic, biological, and lifestyle attributes. Its increasing popularity stems from better treatment results, more effective prevention and early diagnosis methods, and improved cost-efficiency. The pharmacovigilance and drug safety software market facilitates personalized medicine through the integration of pharmacogenetics, real-time data analysis, and post-marketing surveillance, aiming to enhance patient safety, oversee customized treatments, and reinforce risk management. For example, data from February 2024, provided by the Personalized Medicine Coalition (PMC), a US-based non-profit organization, revealed that the FDA approved 16 new personalized therapies for rare diseases in 2023, a significant increase from 6 approvals in 2022. Consequently, the expanding demand for personalized medicine is acting as a key driver for the growth of the pharmacovigilance and drug safety software market.

How Is The Pharmacovigilance And Drug Safety Software Market Examined Through Segment Analysis?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

Which Trends Are Expected To Shape The Pharmacovigilance And Drug Safety Software Market?

Major companies operating in the pharmacovigilance and drug safety software market are prioritizing the development of innovative technologies, such as cloud-based data lake platforms, to enhance adverse event monitoring, improve regulatory compliance, and elevate overall patient safety across clinical trials and post-market surveillance. A cloud-based data lake platform is defined as a scalable, centralized system capable of storing and analyzing vast quantities of structured and unstructured safety data in real time, thereby enabling advanced analytics, AI/ML modeling, and more efficient case processing within pharmacovigilance workflows. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced CorEvidence, its proprietary cloud-based data lake platform crafted to optimize pharmacovigilance processes by boosting safety data management and case processing efficiency, specifically supporting post-authorization safety studies within clinical research registries.

Which Industry Players Are Present In The Pharmacovigilance And Drug Safety Software Market?

Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel

Access The Complete Pharmacovigilance And Drug Safety Software Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Which Region Stands As The Largest Contributor To The Pharmacovigilance And Drug Safety Software Market?

North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmacovigilance And Drug Safety Software Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance And Drug Safety Software Market 2026, By The Business Research Company

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Patient Safety And Risk Management Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Therapeutic Drug Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Pharmacovigilance And Drug Safety Software Market Expected To Reach Based On Its 2026 Value?

The pharmacovigilance and drug safety software market has seen substantial growth in recent years. Its value is expected to rise from $2.53 billion in 2025 to $2.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.8%. This historical expansion can be attributed to an increase in adverse drug reaction reporting, the globalization of clinical trials, the implementation of more stringent drug safety regulations, an increase in pharmaceutical production, and the growing demand for post-marketing surveillance.

The pharmacovigilance and drug safety software market size is projected for substantial expansion over the upcoming years, reaching $4.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period is driven by factors such as the increasing deployment of AI-driven signal detection, the proliferation of biologics and specialty drugs, heightened regulatory scrutiny, a rise in the outsourcing of pharmacovigilance services, and the need for real-time safety analytics. Key developments expected in this period encompass the wider embrace of cloud-based pharmacovigilance platforms, a greater emphasis on monitoring real-world evidence, increased automation in reporting adverse events, the broadening of integrated drug safety systems, and a heightened requirement for regulatory compliance solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Primary Drivers Are Shaping The Pharmacovigilance And Drug Safety Software Market?

The increasing need for personalized medicine is projected to boost the expansion of the pharmacovigilance and drug safety software market. Personalized medicine, also known as precision medicine, represents a healthcare approach that tailors treatment decisions to an individual’s genetic, biological, and lifestyle characteristics. This demand is escalating due to improved treatment outcomes, enhanced prevention and early detection strategies, and greater cost-effectiveness. The pharmacovigilance and drug safety software market supports personalized medicine by integrating pharmacogenetics, real-time data analytics, and post-marketing surveillance to optimize patient safety, monitor individualized treatments, and strengthen risk-management practices. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 approvals in 2022. Consequently, the growing demand for personalized medicine is driving the growth of the pharmacovigilance and drug safety software market.

What Are The Main Segments Within The Pharmacovigilance And Drug Safety Software Market Segment Structure?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

What Market Trends Are Affecting The Pharmacovigilance And Drug Safety Software Market?

Companies operating in the **pharmacovigilance and drug safety software market** are concentrating on developing innovative technologies, such as cloud-based data lake platforms, to strengthen adverse event monitoring, improve regulatory compliance, and enhance overall patient safety across clinical trials and post-market surveillance activities. A cloud-based data lake platform refers to a scalable, centralized system capable of storing and analyzing large volumes of structured and unstructured safety data in real time, thereby enabling advanced analytics, AI/ML modeling, and streamlined case processing within pharmacovigilance workflows. For instance, in **December 2023**, **Thermo Fisher Scientific Inc., a US-based biotechnology company**, introduced CorEvidence, a proprietary cloud-based data lake platform engineered to optimize pharmacovigilance processes by improving safety data management and case processing efficiency, particularly supporting post-authorization safety studies within clinical research registries.

Who Are The Companies Participating In The Pharmacovigilance And Drug Safety Software Market?

Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel

Get The Full Pharmacovigilance And Drug Safety Software Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Where Is The Pharmacovigilance And Drug Safety Software Market Primarily Concentrated By Region?

North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmacovigilance And Drug Safety Software Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Browse Through More Reports Similar to the Global Pharmacovigilance And Drug Safety Software Market 2026, By The Business Research Company

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Patient Safety And Risk Management Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Therapeutic Drug Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Pharmacovigilance And Drug Safety Software Market In 2026 And What Value Is Projected For 2030?

The pharmacovigilance and drug safety software market size has seen significant expansion in recent years. Its valuation is anticipated to climb from $2.53 billion in 2025 to $2.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. The increase observed in previous periods can be attributed to a rise in adverse drug reaction reporting, the worldwide nature of clinical trials, rigorous drug safety regulations, an uptick in pharmaceutical manufacturing, and the escalating need for post-marketing surveillance.

The pharmacovigilance and drug safety software market size is projected to experience substantial growth in the upcoming years, with expectations to reach $4.6 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is fueled by the expansion of ai-driven signal detection, growth in biologics and specialty drugs, rising regulatory scrutiny, increasing outsourcing of pharmacovigilance services, and demand for real-time safety analytics. Additionally, prominent trends shaping the forecast period include the growing adoption of cloud-based pharmacovigilance platforms, increasing focus on real-world evidence monitoring, rising automation in adverse event reporting, expansion of integrated drug safety systems, and higher demand for regulatory compliance solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Major Drivers Are Influencing Demand In The Pharmacovigilance And Drug Safety Software Market?

The increasing need for personalized medicine is projected to stimulate expansion in the pharmacovigilance and drug safety software market in the future. Personalized medicine, alternatively termed precision medicine, represents a medical strategy that customizes treatment choices based on a person’s genetic makeup, biological profile, and lifestyle attributes. The uptake of personalized medicine is escalating because of better treatment results, advanced methods for prevention and early identification, and improved economic efficiency. The pharmacovigilance and drug safety software market aids personalized medicine through the integration of pharmacogenetics, real-time data analytics, and post-marketing surveillance, thereby optimizing patient safety, overseeing tailored treatments, and reinforcing risk-management procedures. As an example, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that the FDA granted approval to 16 novel personalized therapies for individuals with rare diseases in 2023, which is an increase from 6 approvals recorded in 2022. Consequently, the expanding requirement for personalized medicine is fueling the growth of the pharmacovigilance and drug safety software market.

What Are The Key Segments Of The Pharmacovigilance And Drug Safety Software Market?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

What Key Trends Are Influencing The Development Of The Pharmacovigilance And Drug Safety Software Market?

Leading companies in the pharmacovigilance and drug safety software market are concentrating on developing innovative technologies, including cloud-based data lake platforms, to enhance adverse event monitoring, improve regulatory adherence, and boost overall patient safety across clinical trials and post-market surveillance. A cloud-based data lake platform is defined as a scalable, centralized system able to store and analyze vast quantities of structured and unstructured safety data in real time, enabling advanced analytics, AI/ML modeling, and streamlined case processing within pharmacovigilance workflows. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced CorEvidence, its proprietary cloud-based data lake platform, specifically designed to optimize pharmacovigilance processes by improving safety data management and case processing efficiency, especially for supporting post-authorization safety studies within clinical research registries.

Who Are The Leading Companies Operating In The Pharmacovigilance And Drug Safety Software Market?

Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel

Read the full pharmacovigilance and drug safety software market report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Pharmacovigilance And Drug Safety Software Market?

North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmacovigilance And Drug Safety Software Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance And Drug Safety Software Market 2026, By The Business Research Company

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Patient Safety And Risk Management Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Therapeutic Drug Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmacovigilance and drug safety software market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Pharmacovigilance And Drug Safety Software Market?

The pharmacovigilance and drug safety software market size has observed rapid expansion in recent years. It is projected to increase from $2.53 billion in 2025 to $2.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.8%. The growth experienced in the past can be attributed to factors such as a rise in adverse drug reaction reporting, the globalization of clinical trials, more stringent drug safety regulations, an increase in pharmaceutical production, and rising requirements for post-marketing surveillance.

The pharmacovigilance and drug safety software market is projected for significant expansion in the coming years, reaching $4.6 billion by 2030, propelled by a compound annual growth rate (CAGR) of 12.6%. This anticipated growth stems from factors such as the broader adoption of ai-driven signal detection, the increasing development of biologics and specialty drugs, heightened regulatory scrutiny, the growing trend of outsourcing pharmacovigilance services, and the demand for real-time safety analytics. Key trends identified for this period encompass the increasing integration of cloud-based pharmacovigilance platforms, a sharpened focus on monitoring real-world evidence, greater automation in reporting adverse events, the expansion of integrated drug safety systems, and an elevated demand for regulatory compliance solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Drivers Are Supporting Technological Adoption In The Pharmacovigilance And Drug Safety Software Market?

The increasing requirement for personalized medicine is projected to stimulate the expansion of the pharmacovigilance and drug safety software market moving forward. Personalized medicine, also referred to as precision medicine, is a healthcare strategy that customizes treatment plans to align with an individual’s genetic, biological, and lifestyle attributes. The impetus for personalized medicine is escalating due to its ability to yield better patient outcomes, enhance prevention and early detection approaches, and offer improved cost-effectiveness. The pharmacovigilance and drug safety software market facilitates personalized medicine by incorporating pharmacogenetics, real-time data analytics, and post-marketing surveillance to maximize patient safety, oversee individualized treatments, and reinforce risk-management protocols. For instance, in February 2024, information from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, highlighted that the FDA granted approval to 16 novel personalized therapies for individuals with rare diseases in 2023, which is a considerable increase from the 6 approvals in 2022. Hence, the rising demand for personalized medicine is a significant catalyst for the growth of the pharmacovigilance and drug safety software market.

What Segment Types Are Examined In The Pharmacovigilance And Drug Safety Software Market?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

Which Trends Are Influencing The Performance And Direction Of The Pharmacovigilance And Drug Safety Software Market?

Prominent companies within the pharmacovigilance and drug safety software market are directing their attention towards developing novel technologies, including cloud-based data lake platforms, with the goal of strengthening adverse event monitoring, enhancing regulatory compliance, and improving overall patient safety throughout clinical trials and post-market surveillance. A cloud-based data lake platform signifies a scalable, centralized system equipped to store and analyze significant volumes of structured and unstructured safety data instantaneously, thereby enabling sophisticated analytics, AI/ML modeling, and streamlined case processing within pharmacovigilance workflows. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled CorEvidence, its proprietary cloud-based data lake platform specifically engineered to optimize pharmacovigilance processes by refining safety data management and improving case processing efficiency, particularly in its support for post-authorization safety studies within clinical research registries.

Who Are The Top-Performing Companies In The Pharmacovigilance And Drug Safety Software Market In Recent Years?

Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Which Region Currently Holds The Largest Share Of The Pharmacovigilance And Drug Safety Software Market?

North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmacovigilance And Drug Safety Software Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance And Drug Safety Software Market 2026, By The Business Research Company

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Patient Safety And Risk Management Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Therapeutic Drug Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pentavalent market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Pentavalent Market In The Period 2029-2034?

The pharmacovigilance and drug safety software market size has experienced rapid expansion in recent years. It is anticipated to increase from $2.26 billion in 2024 to $2.53 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.3%. The historical growth in this market can be linked to the rising demand for pharmacovigilance and drug safety software.

The pharmacovigilance and drug safety software market is projected for significant expansion in the coming years, with its size anticipated to reach $4.09 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.7%. This growth during the forecast period is primarily fueled by the increasing occurrence of adverse drug reactions, the globalization of pharmacovigilance, the growing complexity of drug safety regulations, and the rising development of new drugs and therapies. Key trends anticipated in this period include the integration of automation and artificial intelligence, the adoption of cloud-based solutions, ongoing technological advancements, and the progressive digitalization of healthcare.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Strategic Drivers Are Accelerating The Pentavalent Market Expansion?

The increasing need for individualized medicine is anticipated to drive expansion in the pharmacovigilance and drug safety software market in the future. Personalized medicine, also referred to as precision medicine, represents a healthcare strategy where decisions and treatments are customized based on each patient’s unique attributes. This rising demand for personalized medicine stems from multiple elements, including enhanced treatment results, an emphasis on disease prevention and prompt identification, and economic efficiency. Critical for the triumph of personalized medicine are pharmacovigilance and drug safety software solutions. Integrating pharmacogenetics, real-time data interpretation, post-market monitoring, and tailored medication data, these tools enhance the safety and effectiveness of bespoke treatments, simultaneously bolstering strong risk management approaches and confronting ethical concerns. An example illustrates this: in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA cleared 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Consequently, the escalating demand for personalized medicine is fueling the expansion of the pharmacovigilance and drug safety software market.

What Is The Detailed Segment Distribution Of The Pentavalent Market?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

How Are Global Trends Impacting The Development Of The Pentavalent Market?

Leading companies within the pharmacovigilance and drug safety software market are actively developing novel technologies, such as cloud-based data lake platforms. These innovations aim to bolster patient safety, more efficiently monitor adverse events, and strengthen regulatory compliance across clinical trials and post-market surveillance of medical devices. A cloud-based data lake platform is defined as a scalable, centralized storage system, empowering organizations to house, manage, and analyze extensive volumes of both structured and unstructured data. It facilitates real-time data access and supports sophisticated analytics alongside AI/ML workloads. As an illustration, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled CorEvidence, a proprietary cloud-based data lake platform. This platform was specifically created to improve pharmacovigilance processes within clinical research registries, thereby streamlining case processing and safety data management, particularly for post-authorization safety studies.

Who Are The Major Stakeholders Operating In The Pentavalent Market?

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Pentavalent Market?

North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp

Browse Through More Reports Similar to the Global Pentavalent Market 2025, By The Business Research Company

Pharmacovigilance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Automotive Safety Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-safety-systems-global-market-report

Patient Safety And Risk Management Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Pharmacovigilance And Drug Safety Software Market Today And What Is Its Future Size?

In recent times, the pharmacovigilance and drug safety software market has experienced swift growth. It is projected to elevate from $2.26 billion in 2024 to $2.53 billion in 2025, with a compound annual growth rate (CAGR) of 12.3%. The expansion in the previous years is predominantly due to the rising demand for pharmacovigilance and drug safety software.

In the upcoming years, the pharmacovigilance and drug safety software market is predicted to witness a robust expansion. It is anticipated to escalate to $4.09 billion by 2029, boasting a compound annual growth rate (CAGR) of 12.7%. The surge during the projected timeline is credited to the escalating instances of negative drug reactions and the worldwide spread of pharmacovigilance, amplified incidences of adverse drug responses, heightened intricacy in drug safety norms, augment in the development of novel drugs and treatments, increasing cases of adverse drug reactions (ADRs), and an increase in the frequency of drug side effects. Noteworthy trends during the forecast timeframe encompass automation and AI amalgamation, cloud-centric solutions, technological novelty, advancements in technology, and the growing digitalization in healthcare.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Drivers Are Accelerating Expansion Of The Pharmacovigilance And Drug Safety Software Market?

The pharmacovigilance and drug safety software market is predicted to experience growth due to the increasing demand for personalized medicine. Personalized or precision medicine is a healthcare approach that customizes decisions and treatments to an individual patient’s unique traits. The rising demand for this type of medicine can be attributed to several factors, including better treatment results, a focus on prevention and early detection, and cost-effectiveness. Pharmacovigilance and drug safety software play a crucial role in personalized medicine, enhancing the safety and effectiveness of treatments tailored to the individual through the inclusion of pharmacogenetics, real-time data analysis, post-marketing monitoring, and personalized medication information. They also address ethical considerations and support thorough risk management strategies. For instance, the Personalized Medicine Coalition, a non-profit organization based in the US, noted that in February 2024, the FDA had approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the 6 approved in 2022. This rising demand for personalized medicine is thus a driving force behind the growth of the pharmacovigilance and drug safety software market.

How Is The Pharmacovigilance And Drug Safety Software Market Segmented Across Key Categories?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

What Key Trends Are Driving Growth In The Pharmacovigilance And Drug Safety Software Market?

Leading firms in the pharmacovigilance and drug safety software market are pioneering novel technologies like cloud-based data lake platforms to bolster patient safety, streamline the monitoring of adverse events, and increase regulatory compliance in clinical trials and medical device post-market surveillance. A cloud-based data lake platform is a versatile, centralised storage system designed to store, control, and examine large quantities of both structured and unstructured data. It enables immediate data access and accommodates sophisticated analytics as well as AI/ML workloads. Take, for example, Thermo Fisher Scientific Inc., an American biotechnology firm, which in December 2023 introduced CorEvidence, a ground-breaking proprietary cloud-based data lake platform devised to boost pharmacovigilance procedures within clinical research registries. The aim of this platform is to fine-tune case processing and safety data management, particularly for post-authorization safety studies.

Who Are The Major Stakeholders Operating In The Pharmacovigilance And Drug Safety Software Market?

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

How Do Regional Dynamics Influence The Pharmacovigilance And Drug Safety Software Market Performance?

North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Pentavalent Sector?

The market size for pharmacovigilance and drug safety software has experienced swift expansion in the past few years. It is projected to increase from $2.26 billion in 2024 to $2.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.3%. The substantial growth during the historical phase is due to the escalating demand for pharmacovigilance and drug safety software.

The market for pharmacovigilance and drug safety software is anticipated to expand quickly in the upcoming years, expected to soar to “$4.09 billion in 2029 with a compound annual growth rate (CAGR) of 12.7%. Factors contributing to this anticipated growth during the predicted time include a rise in instances of adverse drug reactions, an expansion of pharmacovigilance on a global level, growing complexity in drug safety regulations, advances in the development of new drugs and therapies, and an increase in cases of adverse drug reactions (ADRs). The forecast period is expected to witness trends such as the integration of automation and AI, adoption of cloud-based solutions, technological innovation, advancements in technology and an increase in the digitisation of healthcare.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Forces Are Driving The Growth Of The Pentavalent Market?

The escalating occurrence of diphtheria is anticipated to positively impact the growth of the pentavalent market in the future. The bacterium known as Corynebacterium diphtheriae is responsible for the severe and highly infectious disease named Diphtheria. This condition can cause serious issues with eating and breathing, as well as potentially leading to skin ulcers. By administering a three-dose pentavalent vaccine regimen, children can be safeguarded against diphtheria diseases, hence, the growing occurrence of diphtheria has led to an increased need for pentavalent vaccines. For instance, in 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported an unusually high number of diphtheria cases across June and August 2022 through the International Health Regulations (IHR) reporting process. Out of seven nations, 144 cases of diphtheria were reported, with a significant proportion amongst asylum seekers. Of these 144 patients, 97 (69%) were clinically compatible, 44(31%) were confirmed to have toxigenic diphtheria by laboratory tests, and 3 (2%) were regarded as suspected cases. Hence, the growing occurrence of diphtheria is a significant driving force propelling the expansion of the pentavalent market.

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

What Trends Are Currently Influencing Growth In The Pentavalent Market?

Key players in the pharmacovigilance and drug safety software market are pioneering the use of cutting-edge technologies, such as cloud-based data lake platforms. These platforms play a significant role in enhancing patient safety, improving adverse event monitoring, and assuring regulatory compliance in both clinical trials and post-market observation of medicinal devices. Essentially, a cloud-based data lake platform is a flexible, centralized storage system that facilitates the storage, management, and analysis of massive quantities of structured and unstructured data. It allows real-time access to data and facilitates advanced analysis and AI/ML workloads. For instance, Thermo Fisher Scientific Inc., a notable biotechnology firm based in the United States, rolled out CorEvidence in December 2023. CorEvidence is a patented cloud-based data lake platform designed to boost pharmacovigilance procedures within clinical research records. The platform is geared towards streamlining case handling and safety data management, especially concerning post-authorization safety trials.

Which Companies Currently Dominate The Competitive Landscape In The Pentavalent Industry?

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

Which Geographic Regions Are Driving Demand In The Pentavalent Market?

North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pharmacovigilance And Drug Safety Software Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for pharmacovigilance and drug safety software has experienced a significant increase lately. The market forecast shows a rise from $2.26 billion in 2024 to $2.53 billion in 2025, representing a compound annual growth rate (CAGR) of 12.3%. Historically, the growth has been driven by a heightened demand for pharmacovigilance and drug safety software.

The market size of pharmacovigilance and drug safety software is projected to experience a significant surge in the coming years, with an expected growth up to $4.09 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.7%. This expansion during the forecast period is largely due to an upswing in adverse drug reaction cases and the worldwide spread of pharmacovigilance. Other contributing factors include a rise in adverse drug reactions, the growing intricacies in drug safety regulations, a surge in the creation of new drugs and therapies, and an increase in adverse drug reaction (ADR) incidents. In the forecast period, key trends to watch out for include the integration of automation and AI, cloud-based solutions, technological innovation, advancements in technologies, and a growing trend towards healthcare digitalization.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

What Are the Core Market Drivers Propelling Growth in the Pharmacovigilance And Drug Safety Software Industry?

The expansion of the pharmacovigilance and drug safety software market is projected to be fuelled by the increasing need for personalized or precision medicine. This particular medical practice, which customizes healthcare choices and therapies based on each patient’s specifics, is gaining popularity due to factors like enhanced treatment results, emphasis on prevention and early diagnosis, and affordability. Pharmacovigilance and drug safety software play an essential role within personalized medicine, their key contributions being pharmacogenetics, real-time data analysis, post-marketing surveillance, and tailored medication information, all contributing towards more secure and effective individual therapies, efficient risk management, and handling ethical considerations. The Personalized Medicine Coalition, a non-profit organization based in the US, recorded in February 2024 that the FDA had granted approval to 16 new personalized therapies in 2023 for patients with uncommon diseases, a considerable jump from just 6 in 2022. This surge in demand for personalized medicine is, therefore, a significant driver for the pharmacovigilance and drug safety software market’s growth.

How Is the Pharmacovigilance And Drug Safety Software Market Segmented?

The pharmacovigilance and drug safety software market covered in this report is segmented –

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software

2) By Delivery Mode: On-premise, Cloud-based

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:

1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications

2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules

3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms

4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp

Which Regions Are Driving the Next Phase of the Pharmacovigilance And Drug Safety Software Market Growth?

North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Pharmacovigilance And Drug Safety Software Industry?

Leading businesses in the pharmacovigilance and drug safety software market are focusing on creating cutting-edge technologies, such as cloud-based data lake platforms. This innovation aims to boost patient safety, effectively monitor adverse incidents, and enhance regulatory adherence in clinical studies and post-market medical device monitoring. Cloud-based data lake platforms, centrally scalable storage systems, enable organizations to store, manage, and examine large volumes of both structured and unstructured data. It also provides instantaneous data access and supports advanced analytical and AI/ML workloads. For example, in December 2023, Thermo Fisher Scientific Inc., a biotech firm from the United States, introduced CorEvidence, a novel, proprietary cloud-based data lake platform developed to improve pharmacovigilance protocols in clinical research registries. The platform’s objective is to streamline case processing and safety data handling, particularly in post-authorization safety investigations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

How Is the Pharmacovigilance And Drug Safety Software Market Defined and What Are Its Core Parameters?

Pharmacovigilance and drug safety software refers to a suite of digital tools designed to monitor, analyze, and report adverse drug reactions (ADRs) and other safety-related information associated with pharmaceuticals and medical products. This software plays a critical role in ensuring patient safety and regulatory compliance throughout the lifecycle of a drug, from development to post-marketing surveillance.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19140

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model